FINWIRES · TerminalLIVE
FINWIRES

Chevron's Renewable-Fuels Upside Overlooked Ahead of 2026 Margin Rebound, UBS Says

-- Chevron's (CVX) capacity expansion at its Geismar facility in Louisiana is Underappreciated due to weak renewable diesel and biodiesel margins in 2025, UBS Securities said Monday in a report.

The Environmental Protection Agency's revised Renewable Volume Obligations mandate a sharp increase in biomass-based diesel blending, which UBS said should drive a "very strong inflection" in earnings cash flow from 2026 to 2028. Chevron is expected to generate $440 million in incremental EBITDA over that period, the report said.

Chevron's joint venture with Bunge Global (BG) expanded soybean-processing capacity and added switch capability, giving the company direct exposure to soy and softseed crush margins, UBS said.

Diesel and crush margins are likely to be materially higher in 2026, contributing an incremental $1 billion to Chevron's cash flows, the report said.

UBS reiterated its buy rating on Chevron stock with a price target of $218.

Chevron shares fell 2.6% in Tuesday trading, and Bunge rose 0.2%.

Price: $186.72, Change: $-5.06, Percent Change: -2.64%

Related Articles

Asia

Shakti Pumps (India) Invests INR100 Million in EV Mobility Unit

Shakti Pumps (India) (NSE:SHAKTIPUMP, BOM:531431) said it has invested 100 million Indian rupees in its wholly owned subsidiary Shakti EV Mobility by subscribing to 10 million equity shares, according to a Tuesday filing to the Indian stock exchanges.Shares of the company rose 1% in Wednesday's trade.With this, Shakti Pumps' total investment in the EV mobility unit has increased to 650 million Indian rupees, the filing said.The investment is aimed at supporting business expansion of the subsidiary, it added.

$BOM:531431$NSE:SHAKTIPUMP
Asia

Challenger's Fiscal 2026 Q3 Update Missed Consensus Across Key Life Metrics, Jarden Says

Challenger's (ASX:CGF) fiscal 2026 third-quarter update missed consensus across key Life metrics, with FM outflows significantly worse than expected, driven by institutional equity mandate attrition in both Australian and global equities, according to a Tuesday note by Jarden.The firm's redemption of all CGFPC notes on May 25 simplifies the capital structure, reduces the AT1 coupon burden, and is earnings-per-share accretive.Jarden sees balanced risk/reward for Challenger in the future, with catalysts including capital management flexibility from the Australian Prudential Regulation Authority reform, as well as expanding retirement partnerships across superfunds.It lowered its fiscal 2026 sales forecast to reflect weaker institutional fixed-term sales, partially offset by higher retail annuity sales as partnerships come online.The investment firm retained its neutral rating on Challenger and raised the price target to AU$8.70 per share from AU$8.60 per share.

$ASX:CGF
Asia

Proya Cosmetics 2025 Profit Down 4%, Revenue Slips 2%

Proya Cosmetics (SHA:603605) posted 2025 attributable net profit of 1.50 billion yuan, down 3.5% from 1.55 billion yuan the previous year.Earnings per share slid to 3.80 yuan from 3.92 yuan, according to a Wednesday filing with the Shanghai bourse.Operating revenue declined 1.7% year over year to 10.6 billion yuan from 10.8 billion yuan.Shares of the cosmetics maker were up over 1% in recent trade.

$SHA:603605